nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—CA3—pericardium—malignant mesothelioma	0.0936	0.0936	CbGeAlD
Nilotinib—CDC42BPB—decidua—malignant mesothelioma	0.0229	0.0229	CbGeAlD
Nilotinib—MAPK8—epithelium—malignant mesothelioma	0.0219	0.0219	CbGeAlD
Nilotinib—TIE1—epithelium—malignant mesothelioma	0.019	0.019	CbGeAlD
Nilotinib—MAP4K1—decidua—malignant mesothelioma	0.0188	0.0188	CbGeAlD
Nilotinib—TIE1—decidua—malignant mesothelioma	0.0179	0.0179	CbGeAlD
Nilotinib—FRK—testis—malignant mesothelioma	0.0172	0.0172	CbGeAlD
Nilotinib—EPHA8—testis—malignant mesothelioma	0.0157	0.0157	CbGeAlD
Nilotinib—HCK—decidua—malignant mesothelioma	0.0157	0.0157	CbGeAlD
Nilotinib—CDC42BPB—lung—malignant mesothelioma	0.0154	0.0154	CbGeAlD
Nilotinib—MAPK11—testis—malignant mesothelioma	0.0146	0.0146	CbGeAlD
Nilotinib—EPHA3—lung—malignant mesothelioma	0.0146	0.0146	CbGeAlD
Nilotinib—CDC42BPB—testis—malignant mesothelioma	0.0145	0.0145	CbGeAlD
Nilotinib—MAPK8—lung—malignant mesothelioma	0.0139	0.0139	CbGeAlD
Nilotinib—MAPK14—epithelium—malignant mesothelioma	0.0139	0.0139	CbGeAlD
Nilotinib—EPHA3—testis—malignant mesothelioma	0.0138	0.0138	CbGeAlD
Nilotinib—EPHB4—epithelium—malignant mesothelioma	0.0132	0.0132	CbGeAlD
Nilotinib—MAPK14—decidua—malignant mesothelioma	0.0131	0.0131	CbGeAlD
Nilotinib—MAPK8—testis—malignant mesothelioma	0.0131	0.0131	CbGeAlD
Nilotinib—EPHA6—testis—malignant mesothelioma	0.0131	0.0131	CbGeAlD
Nilotinib—FGR—decidua—malignant mesothelioma	0.0131	0.0131	CbGeAlD
Nilotinib—LCK—decidua—malignant mesothelioma	0.0131	0.0131	CbGeAlD
Nilotinib—EPHA2—epithelium—malignant mesothelioma	0.0129	0.0129	CbGeAlD
Nilotinib—MAP4K1—lung—malignant mesothelioma	0.0126	0.0126	CbGeAlD
Nilotinib—TEK—epithelium—malignant mesothelioma	0.0126	0.0126	CbGeAlD
Nilotinib—EPHB4—decidua—malignant mesothelioma	0.0125	0.0125	CbGeAlD
Nilotinib—EPHA2—decidua—malignant mesothelioma	0.0122	0.0122	CbGeAlD
Nilotinib—TIE1—lung—malignant mesothelioma	0.0121	0.0121	CbGeAlD
Nilotinib—MAP4K1—testis—malignant mesothelioma	0.0119	0.0119	CbGeAlD
Nilotinib—TEK—decidua—malignant mesothelioma	0.0119	0.0119	CbGeAlD
Nilotinib—BRAF—lung—malignant mesothelioma	0.0116	0.0116	CbGeAlD
Nilotinib—EPHB3—lung—malignant mesothelioma	0.0115	0.0115	CbGeAlD
Nilotinib—EPHB6—decidua—malignant mesothelioma	0.0114	0.0114	CbGeAlD
Nilotinib—TIE1—testis—malignant mesothelioma	0.0114	0.0114	CbGeAlD
Nilotinib—BRAF—testis—malignant mesothelioma	0.0109	0.0109	CbGeAlD
Nilotinib—EPHB3—testis—malignant mesothelioma	0.0108	0.0108	CbGeAlD
Nilotinib—PDGFRA—decidua—malignant mesothelioma	0.0108	0.0108	CbGeAlD
Nilotinib—HCK—lung—malignant mesothelioma	0.0105	0.0105	CbGeAlD
Nilotinib—ABL2—lung—malignant mesothelioma	0.0105	0.0105	CbGeAlD
Nilotinib—HCK—testis—malignant mesothelioma	0.00995	0.00995	CbGeAlD
Nilotinib—ABL2—testis—malignant mesothelioma	0.00989	0.00989	CbGeAlD
Nilotinib—MAP2K5—decidua—malignant mesothelioma	0.00974	0.00974	CbGeAlD
Nilotinib—EPHA4—lung—malignant mesothelioma	0.00958	0.00958	CbGeAlD
Nilotinib—CSF1R—decidua—malignant mesothelioma	0.00951	0.00951	CbGeAlD
Nilotinib—CA3—lung—malignant mesothelioma	0.00947	0.00947	CbGeAlD
Nilotinib—KIT—epithelium—malignant mesothelioma	0.00914	0.00914	CbGeAlD
Nilotinib—EPHA4—testis—malignant mesothelioma	0.00904	0.00904	CbGeAlD
Nilotinib—CA3—testis—malignant mesothelioma	0.00893	0.00893	CbGeAlD
Nilotinib—PDGFRB—epithelium—malignant mesothelioma	0.00892	0.00892	CbGeAlD
Nilotinib—MAPK14—lung—malignant mesothelioma	0.00884	0.00884	CbGeAlD
Nilotinib—LCK—lung—malignant mesothelioma	0.0088	0.0088	CbGeAlD
Nilotinib—FGR—lung—malignant mesothelioma	0.0088	0.0088	CbGeAlD
Nilotinib—KIT—decidua—malignant mesothelioma	0.00863	0.00863	CbGeAlD
Nilotinib—CA9—testis—malignant mesothelioma	0.00855	0.00855	CbGeAlD
Nilotinib—PDGFRB—decidua—malignant mesothelioma	0.00843	0.00843	CbGeAlD
Nilotinib—EPHB4—lung—malignant mesothelioma	0.00838	0.00838	CbGeAlD
Nilotinib—MAPK14—testis—malignant mesothelioma	0.00834	0.00834	CbGeAlD
Nilotinib—FGR—testis—malignant mesothelioma	0.0083	0.0083	CbGeAlD
Nilotinib—LCK—testis—malignant mesothelioma	0.0083	0.0083	CbGeAlD
Nilotinib—EPHA2—lung—malignant mesothelioma	0.00822	0.00822	CbGeAlD
Nilotinib—TEK—lung—malignant mesothelioma	0.00802	0.00802	CbGeAlD
Nilotinib—EPHB4—testis—malignant mesothelioma	0.0079	0.0079	CbGeAlD
Nilotinib—EPHA2—testis—malignant mesothelioma	0.00775	0.00775	CbGeAlD
Nilotinib—EPHB6—lung—malignant mesothelioma	0.00766	0.00766	CbGeAlD
Nilotinib—TEK—testis—malignant mesothelioma	0.00756	0.00756	CbGeAlD
Nilotinib—ABL1—decidua—malignant mesothelioma	0.00751	0.00751	CbGeAlD
Nilotinib—PDGFRA—lung—malignant mesothelioma	0.00726	0.00726	CbGeAlD
Nilotinib—EPHB6—testis—malignant mesothelioma	0.00723	0.00723	CbGeAlD
Nilotinib—PDGFRA—testis—malignant mesothelioma	0.00685	0.00685	CbGeAlD
Nilotinib—CA12—lung—malignant mesothelioma	0.0067	0.0067	CbGeAlD
Nilotinib—MAP2K5—lung—malignant mesothelioma	0.00655	0.00655	CbGeAlD
Nilotinib—CSF1R—lung—malignant mesothelioma	0.00639	0.00639	CbGeAlD
Nilotinib—MAP2K5—testis—malignant mesothelioma	0.00618	0.00618	CbGeAlD
Nilotinib—CSF1R—testis—malignant mesothelioma	0.00603	0.00603	CbGeAlD
Nilotinib—KIT—lung—malignant mesothelioma	0.00581	0.00581	CbGeAlD
Nilotinib—PDGFRB—lung—malignant mesothelioma	0.00567	0.00567	CbGeAlD
Nilotinib—KIT—testis—malignant mesothelioma	0.00548	0.00548	CbGeAlD
Nilotinib—CA2—epithelium—malignant mesothelioma	0.00542	0.00542	CbGeAlD
Nilotinib—PDGFRB—testis—malignant mesothelioma	0.00535	0.00535	CbGeAlD
Nilotinib—CA1—lung—malignant mesothelioma	0.00531	0.00531	CbGeAlD
Nilotinib—CA2—decidua—malignant mesothelioma	0.00512	0.00512	CbGeAlD
Nilotinib—ABL1—lung—malignant mesothelioma	0.00505	0.00505	CbGeAlD
Nilotinib—ABL1—testis—malignant mesothelioma	0.00477	0.00477	CbGeAlD
Nilotinib—ABCG2—decidua—malignant mesothelioma	0.00474	0.00474	CbGeAlD
Nilotinib—CA4—lung—malignant mesothelioma	0.00415	0.00415	CbGeAlD
Nilotinib—CA4—testis—malignant mesothelioma	0.00392	0.00392	CbGeAlD
Nilotinib—CA2—lung—malignant mesothelioma	0.00344	0.00344	CbGeAlD
Nilotinib—CA2—testis—malignant mesothelioma	0.00325	0.00325	CbGeAlD
Nilotinib—ABCG2—lung—malignant mesothelioma	0.00319	0.00319	CbGeAlD
Nilotinib—CYP2C8—testis—malignant mesothelioma	0.00309	0.00309	CbGeAlD
Nilotinib—ABCG2—testis—malignant mesothelioma	0.00301	0.00301	CbGeAlD
Nilotinib—CYP2B6—lung—malignant mesothelioma	0.00294	0.00294	CbGeAlD
Nilotinib—CYP2B6—testis—malignant mesothelioma	0.00277	0.00277	CbGeAlD
Nilotinib—ABCB1—epithelium—malignant mesothelioma	0.00247	0.00247	CbGeAlD
Nilotinib—ABCB1—decidua—malignant mesothelioma	0.00234	0.00234	CbGeAlD
Nilotinib—CYP2D6—testis—malignant mesothelioma	0.00206	0.00206	CbGeAlD
Nilotinib—ABCB1—lung—malignant mesothelioma	0.00157	0.00157	CbGeAlD
Nilotinib—ABCB1—testis—malignant mesothelioma	0.00148	0.00148	CbGeAlD
